tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

BCLI Stock Latest News

Brainstorm Cell Therapeutics: Balancing Hope and Financial Hurdles
Company AnnouncementsBrainstorm Cell Therapeutics: Balancing Hope and Financial Hurdles
8d ago
BCLI
BrainStorm Cell Therapeutics Reports Q2 2025 Progress
PremiumCompany Announcements
BrainStorm Cell Therapeutics Reports Q2 2025 Progress
25d ago
BCLI
BrainStorm downgraded to Hold from Buy at Maxim
PremiumThe Fly
BrainStorm downgraded to Hold from Buy at Maxim
2M ago
BCLI
Brainstorm Cell Therapeutics Faces Nasdaq Delisting Notice
PremiumCompany Announcements
Brainstorm Cell Therapeutics Faces Nasdaq Delisting Notice
2M ago
8K
BCLI
BrainStorm announces Nasdaq delisting and transition to OTCQB
PremiumThe Fly
BrainStorm announces Nasdaq delisting and transition to OTCQB
2M ago
BCLI
Brainstorm Cell Therapeutics Approves Stock Plan Amendments
PremiumCompany AnnouncementsBrainstorm Cell Therapeutics Approves Stock Plan Amendments
3M ago
8K
BCLI
BrainStorm files to sell 2.76M shares of common stock for holders
Premium
The Fly
BrainStorm files to sell 2.76M shares of common stock for holders
3M ago
BCLI
Promising Survival Data and Regulatory Progress Bolster Buy Rating for Brainstorm Cell Therapeutics
Premium
Ratings
Promising Survival Data and Regulatory Progress Bolster Buy Rating for Brainstorm Cell Therapeutics
3M ago
BCLI
BrainStorm reports new survival data from EAP for NurOwn
PremiumThe Fly
BrainStorm reports new survival data from EAP for NurOwn
3M ago
BCLI
Strategic Advancements and Potential of BrainStorm Cell Therapeutics: A Buy Recommendation by Jason McCarthy
PremiumRatings
Strategic Advancements and Potential of BrainStorm Cell Therapeutics: A Buy Recommendation by Jason McCarthy
3M ago
BCLI
BrainStorm signs LOI with Minaris to manufacture NurOwn
PremiumThe Fly
BrainStorm signs LOI with Minaris to manufacture NurOwn
3M ago
BCLI
PLUR
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
4M ago
TIL
ARMP
Biotech Alert: Searches spiking for these stocks today
PremiumThe FlyBiotech Alert: Searches spiking for these stocks today
4M ago
SNY
ARMP
Buy Rating for BrainStorm Cell Therapeutics: Strategic Advancements and Promising ALS Therapy Developments
Premium
Ratings
Buy Rating for BrainStorm Cell Therapeutics: Strategic Advancements and Promising ALS Therapy Developments
4M ago
BCLI
Brainstorm Cell Therapeutics Reports Q1 2025 Financials
Premium
Company Announcements
Brainstorm Cell Therapeutics Reports Q1 2025 Financials
4M ago
BCLI
Brainstorm Cell Therapeutics: Progress and Challenges in ALS Trial
PremiumCompany Announcements
Brainstorm Cell Therapeutics: Progress and Challenges in ALS Trial
4M ago
BCLI
One new option listing and nine option delistings on May 19th
PremiumThe Fly
One new option listing and nine option delistings on May 19th
4M ago
J
DFS
BrainStorm receives FDA clearance to initiate Phase 3b clinical trial of NurOwn
PremiumThe Fly
BrainStorm receives FDA clearance to initiate Phase 3b clinical trial of NurOwn
4M ago
BCLI
BrainStorm submits IND amendment to FDA for Phase 3b trial of NurOwn in ALS
PremiumThe Fly
BrainStorm submits IND amendment to FDA for Phase 3b trial of NurOwn in ALS
5M ago
BCLI
BrainStorm Cell Therapeutics Reports 2024 Financial Results
PremiumCompany AnnouncementsBrainStorm Cell Therapeutics Reports 2024 Financial Results
5M ago
BCLI
BrainStorm Cell Therapeutics’ Earnings Call Highlights Progress and Challenges
Premium
Company Announcements
BrainStorm Cell Therapeutics’ Earnings Call Highlights Progress and Challenges
5M ago
BCLI
BCLI Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
BCLI Earnings this Week: How Will it Perform?
5M ago
BCLI

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >